Life Science Company News

Results 61 - 80 out of 500 displayed.
«  1  2  3 4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

LifeMD to Participate in Upcoming Investor and Industry Conferences During May

Read more ››
By: GlobeNewswire - 23 Apr 2024

Phase 2 RIZE Study Sub-Analyses to be Presented at the 2024 Pediatric Endocrine Society Annual Meeting

Read more ››
By: GlobeNewswire - 23 Apr 2024

EDAP Announces Final Results from HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy to be Presented During Plenary Session at the Upcoming 119th American Urological Association (AUA) Annual Meeting

Read more ››
By: GlobeNewswire - 23 Apr 2024

DiagnaMed Announces Canadian Launch of BRAIN AGE® Brain Health AI

Read more ››
By: GlobeNewswire - 23 Apr 2024

PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting

Read more ››
By: GlobeNewswire - 23 Apr 2024

INmune Bio Inc. Announces 24-Month Stability Validation of XPro™ for Phase III Readiness and Commercial Supply Chain Modeling & Development of Novel Immunogenicity Assay

Read more ››
By: GlobeNewswire - 23 Apr 2024

PDS Biotech to Host Key Opinion Leader Event to Discuss Positive, Updated Data from Phase 2 VERSATILE-002 Clinical Trial with Versamune® HPV in Combination with KEYTRUDA® in Recurrent or Metastatic Head and Neck Cancer

Read more ››
By: GlobeNewswire - 23 Apr 2024

Tome Biosciences to Present Data on Programmable Genomic Integration Technologies at ASGCT

Read more ››
By: GlobeNewswire - 23 Apr 2024

OncoC4 Announces FDA Clearance of IND Application for Novel SIGLEC 10 Immune Checkpoint Inhibitor ONC-841 for Solid Tumors

Read more ››
By: GlobeNewswire - 23 Apr 2024

Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1

Read more ››
By: GlobeNewswire - 23 Apr 2024

BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)

Read more ››
By: GlobeNewswire - 23 Apr 2024

Sania Therapeutics presents latest from AAV gene therapy platform at the American Society of Gene & Cell Therapy Annual Meeting

Read more ››
By: GlobeNewswire - 23 Apr 2024

USDA Grants Amfora Exemption for Its Patented, Gene-Edited, Ultra-High Protein Soy, Accelerating Path to Market

Read more ››
By: GlobeNewswire - 23 Apr 2024

Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing

Read more ››
By: GlobeNewswire - 23 Apr 2024

Palisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approach

Read more ››
By: GlobeNewswire - 23 Apr 2024

PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101

Read more ››
By: GlobeNewswire - 23 Apr 2024

GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset

Read more ››
By: GlobeNewswire - 23 Apr 2024

Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy

Read more ››
By: GlobeNewswire - 23 Apr 2024

STRATA Skin Sciences to Present at the Planet MicroCap Showcase: Vegas 2024

Read more ››
By: GlobeNewswire - 23 Apr 2024

Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon

Read more ››
By: GlobeNewswire - 23 Apr 2024
Results 61 - 80 out of 500 displayed.
«  1  2  3 4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate